期刊文献+

甲状腺癌的术后随访及监控 被引量:1

原文传递
导出
摘要 分化型甲状腺癌是一个相对惰性病程的恶性肿瘤,也是全身预后较好及可治愈的恶性肿瘤之一。尽管初始治疗采用了全甲状腺切除和/或颈淋巴结清扫、放射性碘治疗及左旋甲状腺素(L-thyroxine,L-T4)抑制治疗等,患者仍有数年后发生复发和转移的可能,而且L-T4治疗需要长期应用。因此,对分化型甲状腺癌的术后随访和监控是非常必要的。
作者 李平栋
出处 《中国医学文摘(耳鼻咽喉科学)》 2012年第4期211-214,共4页 Chinese Medical Digest(Otorhinolaryngology)
  • 相关文献

参考文献16

  • 1Schlumberger MJ. Medical progress: papillary and follicular thyroid carcinoma. N Engl J Med, 1998, 338: 297-306.
  • 2Mazzaferri EL, Kloos RT. Clinical review 126: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab, 2001, 86: 1447-1463.
  • 3Solomon BL, Wartofsky L, Burman KD. Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab, 1996, 81 : 333-339.
  • 4CailleuxAF, Baudin E, Travagli JP, et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab, 2000, 85: 175-178.
  • 5Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J ClinEndocrinol Metab, 2002, 87: 1490-1498.
  • 6Robbins R J, Chon JT, Fleisher M, et al. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab, 2002, 87: 3242-3247.
  • 7Mandel S J, Shankar LK, Benard F, et al. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med, 2001, 26: 6-9.
  • 8Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab, 1999, 84: 3877-3885.
  • 9Wartofsky L. Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement afterrecombinant human thyrotropin. Thyroid, 2002, 12: 583-590.
  • 10Mazzaferri EL, Robbins R J, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab, 2003, 88: 1433-1441.

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部